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Introduction
Patients with autoinflammatory syndromes may present
a clinical course characterized by recurrent, episodic
manifestations (such as fever, skin rash or visceral invol-
vement) or they may show a continuous, unremitting
disease course with persistent clinical manifestations.
Patients with certain diseases, such as CAPS or Blau
syndrome, usually present this type of course.
Objectives
To describe the clinical and genetic features of patients
with continuous-course autoinflammatory syndromes
followed in a tertiary, pediatric hospital.
Methods
Ad-hoc data bases from our autoinflammatory syn-
dromes clinic were reviewed. Patients attended this
clinic between May 2009 and May 2013. Demographic,
clinical, laboratory and genetic data were retrieved.
Autoinflammatory syndrome was defined as the pre-
sence of a chronic, systemic disease with no evidence of
malignancy, infection or autoimmunity. Patients with a
continuous disease course (persistent clinical manifesta-
tions with no free interval and with possible recurrent
exacerbations prior to the initiation of therapy) were
included in the analysis. Patients with a diagnosis of sys-
temic juvenile arthritis were excluded. Genetic analysis
was performed in different locations.
Results
Fourteen children (9 boys) with a continuous disease
course were identified among patients with autoinflam-
matory syndromes. Median age at presentation: 6 months;
median age at diagnosis: 39 months; median follow-up
time: 5 years. Two patients had a positive family history.
Systems involved: constitutional (fever/weight loss/
malaise) 14 patients, skin 14, joints 13, CNS 8, gastroin-
testinal 7, eyes 7, bone 6, mucosae 5, respiratory 4, mus-
cle 2. Acute phase reactants remained permanently
elevated in 10 patients. Growth was impaired In 10 chil-
dren. Eleven patients showed some degree of disability.
Clinical diagnosis were: Blau syndrome (5 patients),
CAPS (4), MKD (1), DIRA (1), CRMO (1), CANDLE (1),
TRAPS (1). Genetic analysis was performed in 12
patients: pathogenic mutations were found in 7 (4 Blau, 2
CAPS, 1 MKD). Patients were treated with different
agents that included steroids (11 patients), methotrexate
(9), anti TNF agents (5), and anti IL-1 agents (5). Eleven
patients improved (8 of them on biologics), 2 patients
remained stable and 1 patient died (suspected DIRA).
Conclusion
Continuous autoinflammatory síndromes are severe sys-
temic diseases that affect growth and functional capacity
of patients. Genetic diagnosis may provide definite diag-
nosis in a proportion of patients. Therapy with biologi-
cal agents leads to better outcomes.
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